Indeed, we can argue that the effectiveness, easy applicability, safe clinical profile and mechanism of BPC 157 (i.eBPC 157/dopamine/glutamate/NO system) represent an alternative, likely successful, future therapeutic direction for neurological conditions. Additional studies have shown that BPC 157 can offer tendon, ligament, and skeletal muscle healing (Gwyer, et al, 2019) it is apparent that BPC 157 has huge potential and following further development has promise as a therapy to conservatively treat or aid recovery in hypovascular and hypocellular soft tissues such as tendon and ligaments
If you're correcting a true deficiency, you might start with weekly injections for 4-6 weeks before moving to a maintenance dose every one to three months
Animal research shows low toxicity
One commenter indicated that hospitals incur annual vendor fees of up to $250,000 to update their MRFs and that even with vendor support, hospitals may have three FTEs spend an entire month developing and validating their MRFs
